Deregulation of the BLVRA activity is a common feature of Alzheimer’s disease, at least in the most advanced stages, with BLVRA inhibition enhancing Tau phosphorylation and deposition in the brain [98,99,100,101] (Table 1 and Table 2). This evidence concerns the gene BLVRA and Alzheimer disease.